Compagnucci, Alexandra;
Chan, Man K;
Saïdi, Yacine;
Cressey, Tim R;
Bamford, Alasdair;
Riault, Yoann;
Coelho, Alexandra;
... Sibanda, N; + view all
(2023)
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.
eClinicalMedicine
, 60
, Article 102025. 10.1016/j.eclinm.2023.102025.
Preview |
PDF
1-s2.0-S258953702300202X-main.pdf - Published Version Download (492kB) | Preview |
Type: | Article |
---|---|
Title: | Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.eclinm.2023.102025 |
Publisher version: | https://doi.org/10.1016/j.eclinm.2023.102025 |
Language: | English |
Additional information: | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third-party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/ |
Keywords: | HIV, Children, Adolescents, Randomised, Paediatrics, Dual therapy, Maintenance, Simplification, Dolutegravir, Darunavir, Virological suppressed |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10171232 |
Archive Staff Only
View Item |